The enhanced expression of ezrin promoted proliferation, invasion and EMT of ovarian cancer cells (Li et al., 2021) and contributed to aggressive tumour characteristics and poor prognosis of breast cancer (Li et al., 2019). Here, EZR is linked to breast carcinoma.